Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
7 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
52.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Ranpak Holdings
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Tariff Hikes Will Hinder Packaging Operations But Automation Will Emerge
Key Takeaways Demand for recyclable packaging is rising, but advanced sustainable alternatives and large buyers threaten Ranpak's growth and pricing power. Automation and innovation investments may drive diversification, yet reliance on major customers and fixed costs create revenue and earnings volatility risks.
View narrative
US$5.00
FV
13.4% undervalued
intrinsic discount
8.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Navitas Semiconductor
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Overvalued Outlook Will Crumble As AI Demand Falters
Key Takeaways Increasing reliance on high-margin markets and emerging applications raises vulnerability to customer concentration and market shifts. Industry commoditization, trade tensions, and heavy R&D investment threaten profitability and may prolong negative free cash flow.
View narrative
US$4.40
FV
53.9% overvalued
intrinsic discount
1.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
ASOS
AN
AnalystLowTarget
Consensus Narrative from 15 Analysts
SHEIN Competition Will Choke Margins With Slight Efficiencies Emerging
Key Takeaways Rising sustainability expectations, inflation, and stiff competition threaten ASOS's revenue growth, profitability, and brand reputation. Ongoing challenges in inventory, returns, and regulatory compliance exert persistent pressure on margins and future earnings.
View narrative
UK£2.20
FV
39.5% overvalued
intrinsic discount
-1.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Definitive Healthcare
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Rising HIPAA Compliance And Cyber Threats Will Diminish Value
Key Takeaways Tightening data privacy rules, industry consolidation, and security concerns will shrink market opportunities and diminish revenue growth, margins, and pricing leverage. Increased competition from open-source AI tools and restricted customer IT budgets will accelerate commoditization, weaken earnings, and limit future top-line expansion.
View narrative
US$3.00
FV
31.0% overvalued
intrinsic discount
-2.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Stitch Fix
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Falling Active Customers And Tariffs Will Erode Profitability
Key Takeaways Sustained declines in active clients and shifts toward new apparel models threaten future revenue growth and challenge the viability of Stitch Fix's core business. Rising costs, stronger competition, and economic pressures are compressing margins and jeopardizing ongoing profitability.
View narrative
US$3.00
FV
67.3% overvalued
intrinsic discount
-0.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
OrthoPediatrics
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Rising Global Costs Will Constrain Revenue While Clinics Persist
Key Takeaways Strong international expansion and innovative product launches drive growth, but regulatory challenges and declining birth rates may limit long-term market potential. Margin and earnings growth face risks from cost containment pressures, product commoditization, and dependence on a specialized portfolio vulnerable to larger competitors.
View narrative
US$22.00
FV
12.7% undervalued
intrinsic discount
15.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Standard BioTools
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Academic Funding Cuts Will Challenge Performance Yet Yield Slight Recovery
Key Takeaways Structural weaknesses from declining U.S. academic funding and regulatory risks create near-term growth challenges and ongoing gross margin volatility despite recent product launches and partnerships. Cost-saving and integration initiatives improve margins, but underinvestment in R&D and reliance on volatile large accounts threaten long-term competitiveness and the path to sustainable profitability.
View narrative
US$1.55
FV
18.1% undervalued
intrinsic discount
-24.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
THG
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Privacy Crackdowns And Fierce Amazon Rivalry Will Drive Margins Down
Key Takeaways Rising regulatory and sustainability costs, alongside persistent input inflation, are constraining THG's margins and limiting profitability across core divisions. Increased competition and reliance on data-driven models, combined with reduced diversification post-demerger, threaten revenue growth, market share, and future earnings stability.
View narrative
UK£0.26
FV
18.5% overvalued
intrinsic discount
1.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Orthofix Medical
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Pricing Pressures And Tariffs Will Constrain Margins Yet Allow Recovery
Key Takeaways Demographic trends and innovative products drive growth, but pricing pressures and the need for superior clinical outcomes may limit revenue and margin expansion. Operational changes and revenue concentration create earnings volatility risks, especially amid policy shifts and evolving physician preferences.
View narrative
US$17.00
FV
14.6% undervalued
intrinsic discount
4.15%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies